Jianjun Cheng (University of Illinois at Urbana-Champaign, USA) " In Vivo Ultrasound-Based Molecular Imaging and Image-Guided Therapy of Cancer" Stanislav Emelianov (Georgia Institute of Technology / Emory University School of Medicine, USA) "RNA Nanotechnology for Cancer Targeting Using Nanoparticles with Scaffold, Ligand, and Therapeutics All Composed of RNA" Peixuan Guo (University of Kentucky, USA) "Cell Membrane-Coated Nanoparticles for Drug Delivery and Vaccination"ĭiscussion Leader: Shawn Chen (National Institute of Biomedical Imaging and Bioengineering, NIH, USA) Liangfang Zhang (University of California, San Diego, USA) "Synthetic DNA Vaccines: New Technology for Difficult Targets" "Nanoscale Thermal Phenomena in Magnetic Nanoparticles: Experimental Evidence and Potential Applications in Cancer Nanotechnology"ĭiscussion Leader: Suzie Pun (University of Washington, USA)ĭavid Weiner (University of Pennsylvania, USA) "Targeted Polymeric Nanostructures for Chemotherapy Delivery and Immunodulation"Ĭarlos Rinaldi (University of Florida, USA) Suzie Pun (University of Washington, USA) "Interfering Tumor-Host Interactions with Theranostic Nanomedicines" Ronit Satchi-Fainaro (Sackler School of Medicine, Tel Aviv University, Israel) "Homing Nanoparticles to Molecularly Heterogenous Targets via Bi-Specific Fusion Proteins"ĭiscussion Leader: Carlos Rinaldi (University of Florida, USA)
Samuel Lai (University of North Carolina at Chapel Hill, USA) Shaoyi Jiang (University of Washington, USA) Stealth Nanoparticles and Tumor Penetrating Peptidesĭiscussion Leader: Kazunori Kataoka (University of Tokyo, Japan) "Prison Instead of Poison Cancer Cells by Nanoparticle Targeting Cancer Stem Cells" Yuliang Zhao (Chinese Academy of Sciences, China) "Antibody-Drug Conjugates: Achievements, Challenges and Future" "Polymeric Micellar Nanomedicines for the Treatment of Recalcitrant Cancer Stem Cells" Kazunori Kataoka (University of Tokyo, Japan) "Immune Privilege by T Cell Exclusion from the Tumor Microenvironment"ĭiscussion Leader: Biana Godin Vilentchouk (Houston Methodist Research Institute, USA) "Exploiting Elements of Tumor Stroma for Enhanced Transport of Nanotherapeutics"ĭouglas Fearon (Cold Spring Harbor Laboratory, USA) Welcome / Introductory Comments by GRC Site Staffĭiscussion Leader: Leaf Huang (University of North Carolina, USA)īiana Godin Vilentchouk (Houston Methodist Research Institute, USA)
The conference program will include: tumor microenvironment chemodrugs delivered by nanoparticles stealth mechanism and improvement in nanoparticles gene/siRNA delivery immunotherapy and nano-vaccines novel nano materials early diagnosis of cancer tumor imaging clinical trials. This conference will serve as a major forum of information exchange and personnel networking in the relaxed setting of a Gordon Research Conference. This is strong evidence that cancer nanotechnology is already an established field of study. It is not surprising that the number of publications in cancer nanotechnology had increased rapidly to about 500-600 per year. Nanoparticles also offer an amplification mechanism for bioanalytical detection and sensor devices for cancer markers. Thus, nanoparticles are uniquely suitable for delivering diagnostic and/or imaging agents, chemo and gene drugs, and agents to enhance the activity of immunotherapy to the tumor. Due to the presence of leaky vasculature and defective lymphatic drainage in solid tumors, nanoparticles selectively accumulate in the tumor via the mechanism of the enhanced permeability and retention (EPR) effect. Its application for cancer diagnosis, imaging, therapy, and prognosis has been a focal point of attention in nanomedicine. Nanotechnology is a burgeoning field of study in science and engineering.
0 kommentar(er)
